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Abstract
Introduction: A previous study has suggested that with 
increasing oGTT thresholds there was a statistically increasing 
risk of maternal and fetal morbidity in the form of hypertensive 
disorders complicating pregnancy. The present study aims to 
identify whether this gradient risk is extant with lower blood 
glucose values.
Methodology: A total of 1289 75-gm oGTTs were 
performed during pregnancy. These were divided according 
to their fasting and 2-hour values into categories: A. Fasting 
values ≤4.5 mmol/l (n=316), 4.6-5.5 mmol/l (n=681), and ≥5.6 
mmol/l (n=292); and B. 2-hour values ≤6.5 mmol/l (n=453), 
6.6-8.5 mmol/l (n=433), 8.6-9.5 mmol/l (n=176), and ≥9.6 
mmol/l (n=208). The incidence of hypertensive disease during 
pregnancy, the macrosomia rate, and the mean birth weight 
were assessed in each group. 
Results: The data confirms that a significant rise in the 
incidence of hypertensive disease occurs at a fasting blood 
glucose value of ≥5.6 mmol/l, while the macrosomia rate 
rises after ≥4.6 mmol/l. The mean birth weight increased 
progressively with increasing fasting blood glucose thresholds. 
There is furthermore a progressive rise in the incidence of 
hypertension noted with significance being reached at a 2-hour 
blood glucose value greater than 9.6 mmol/l. However no 
such relationship appears to be present for the incidence of 
macrosomia; and there was no significant differences in mean 
birth weights with increasing 2-hour post-load glucose levels.
Conclusions: The study suggests that fasting blood glucose 
values may be a better indicator of maternal and foetal adverse 
risk outcomes with increased adverse foetal outcomes being 
indicated at levels ≥4.6 mmol/l . The 2-hour post-75g oGTT 
values appear to be useful as adverse risk indicators only at 
levels ≥9.6 mmol/l. 
Introduction
The World Health Organization criteria for the diagnosis of 
abnormal carbohydrate metabolism during pregnancy have been 
set to levels similar to the non-pregnant state.1 These diagnostic 
criteria therefore ignore the physiological changes of pregnancy 
and thus include a significant proportion of pregnant women 
whose carbohydrate metabolism is normal for their pregnant 
state. This observation has led various bodies, including the 
Diabetic Pregnancy Study Group of ESAD and the American 
Diabetes Association, to propose alternative diagnostic criteria 
based on statistical parameters.2,3 We have previously shown 
that the short-term indicator outcomes, such as hypertensive 
disease and macrosomia, in women with WHO elevated but ADA 
normal 2-hour blood glucose post 75g oGTT were mildly but not 
statistically significantly elevated when compared to presumed 
normal glucose tolerance individuals. Women with ADA-
elevated levels had statistically significant higher risks. The risk 
level appeared to follow a relationship with increasing 2-hour 
post-load blood glucose levels.4,5 The present study attempts to 
investigate the risk element of increasing blood glucose levels 
during 75g oGTT to the development of hypertensive disease in 
the mother and macrosomia in the child.
Material and methods
The study reviewed the medical data records of 1289 Maltese 
women who had undergone a 75-g oral glucose tolerance test 
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during the third trimester of pregnancy. These were subdivided 
according to their fasting and 2-hour post-load blood glucose 
values. The fasting values were subdivided into three groups: 
A. ≤4.5 mmol/l (n=237), B. 4.6-5.5 mmol/l (n=760), and C. 
≥5.6 mmol/l (n=292); and the 2-hour values into four groups: 
A. <=6.5 mmol/l (n=453), B. 6.6-8.5 mmol/l (n=433), C. 
8.6-9.5 mmol/l (n=176) and D. ≥9.6 mmol/l (n=208). The 
incidence of hypertensive disease during pregnancy (gestational 
hypertension/pre-eclampsia), the macrosomia rate (birthweight 
≥4.0 kg) and the mean birth weight were assessed in each group. 
Since oral glucose tolerance testing is not routinely carried out 
on all maternities at the hospital, but only in those women who 
are considered at particular risk of GDM; there is the possibility 
that those women with low blood glucose values had risk 
factors other than glucose intolerance that predisposed them 
to hypertensive disease and macrosomic infants.
Statistical significance comparing the outcome indicators 
risks of the various subgroups against the lower glucose 
bracket was tested using the Chi Square test and the students 
t test as appropriate using the MedCalc statistical package. A 
probability value of <0.05 was taken to represent a significant 
correlation.
Results
There appears to be a progressively increasing rise in the 
incidence of hypertensive disease with increasing fasting blood 
glucose levels (Table 1). Statistical significance was however only 
noted with values greater than or equal to 5.6 mmol/l. Thus 
the hypertension rate increased from 7.0% in women with a 
fasting value <=4.5 mmol/l to 10.6% in women with a fasting 
blood glucose value of 4.6-5.5 mmol/l (p=0.09), and to 21.2% 
in women with fasting blood glucose ≥5.6 mmol/l (p<0.0001). 
The macrosomia rate showed a similar progressive increase. The 
rate of macrosomia increased significantly from 8.5% to 13.4% 
(p=0.04) at a fasting blood glucose value of ≥4.6 mmol/l. The 
rate increased further to 16.1% (p=0.007) with higher values. 
The mean birth rate also showed a statistically significant 
increase from 3398 + 473 g to 3523 + 507 g in women with a 
fasting blood glucose ≥5.6 mmol/l..
There appears to be only a mild increase in hypertensive 
disease with increasing 2-hour post-load blood glucose 
levels after 8.6 mmol/l level (p=0.4) but reaching statistical 
significance only with a blood glucose level greater than 
9.6 mmol/l (p=0.003). There was no apparent significant 
relationship between 2-hour blood glucose and the macrosomia 
rate and the mean birth weight (Table 2).
Discussion
The diagnostic criteria for gestational diabetes and IGT 
have remained a contentious issue. In 1980, the World Health 
Organization suggested that the criteria used to diagnose 
diabetes and IGT in the general population could be applied 
to pregnant women. This view was re-endorsed in 1985 and 
1994.1 Thus, the 1994 WHO criteria for gestational impaired 
glucose tolerance still required a plasma glucose ≥ 7.0 mmol/l 
(fasting) or ≥7.8 mmol/l (2 hours). These criteria however 
do not take into account the natural “diabetogenic” effects 
of pregnancy, and it has been argued that these criteria will 
Table 2: 2-hour post load blood glucose thresholds
2-hour post load
blood glucose <=6.5 mmol/l 6.6-8.5 mmol/l 8.6-9.5 mmol/l ≥9.6 mmol/l
 No. % No. % No. % No. % 
 N=453  N=433  N=176  N=208
Maternal PIH/PET 48 10.6 44 10.2 23 13.1 39 18.8
    p=0.9  p=0.4  p=0.003*
Macrosomia (>4.0 kg) 47 11.3 57 13.2 23 13.1 29 13.9
    p=0.3  p=0.4  p=0.8
Mean + s.d.  3462 + 460  3432 ± 524  3436 ± 472  3489 ± 481
Birth weight (gm)    p=0.4   p=0.5  p=0.5
Table 1: Fasting blood glucose thresholds
Fasting blood glucose <=4.5 mmol/l 4.6-5.5 mmol/l ≥5.6 mmol/l
 No. % No. % No. %
 N=316  N=681  N=292 
Maternal PIH/PET 22 7.0 72 10.6 62 21.2
    p=0.09  p<0.0001*
Macrosomia (>4.0 kg) 27 8.5 91 13.4 47 16.1
    p=0.04*  p=0.007*
Birth weight (gm) Mean + s.d.  3398 ± 473  3451 ± 485  3523 ± 507
    p=0.1  p=0.002*
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include a significant proportion of normal pregnant women. 
Various threshold levels have been proposed, generally based 
on statistical models. The criteria currently proposed by the 
American Diabetes Association require two plasma glucose 
values of ≥5.3 mmol/l (fasting) ≥10.0 mmol/l (1 hour) and 
≥8.6 mmol/l (2 hours).3 The latter threshold recommendations 
appear to be slowly being universally accepted having been 
adopted by the European Association of Perinatal Medicine.6 
Our previous studies appeared to confirm the observation that 
cases defined as mild GIGT by the WHO criteria and normal 
by the ADA criteria, i.e. 2-hour blood glucose value of 7.9-8.5 
mmol/l, were not associated with any apparent statistically 
significant increase in maternal and infant short-term morbidity, 
though a non-statistically significant continuum of risk was 
observed.4,5 These observations has been re-confirmed in the 
present study. These observations contrast with a previously 
published study that had shown that there was a continuum 
of risk related to the 2-hour maternal post-75-gram load blood 
glucose level for the probability of having an assisted delivery 
and the likelihood of the baby being admitted to a Special Care 
Unit, even when the 2-hour value was below 8.0 mmol/l .7 The 
significance of the values obtained after a 75-gram glucose load 
has still to be determined by the large-scale Hyperglycaemia and 
Adverse Pregnancy Outcome (HAPO) Study.8 The present study 
has confirmed that significant risk to both mother and child in 
the form of hypertensive disease exhibits itself with post-75 load 
2-hour values greater that 9.6 mmol/l, though there appeared to 
be a non-statistically significant increase exhibited at a 2-hour 
value of 8.6 mmol/l. The risk has been previously shown to 
become even more significant with increasing values.4,5 Since 
oral glucose tolerance testing is not routinely carried out on all 
maternities at the hospital, but only in those women who are 
considered at particular risk of GDM, it is possible that women 
defined as normal glucose tolerance had other risk factors, such 
as obesity and advanced age, that predisposed them to both 
hypertensive disease and macrosomia. This would influence 
statistical significance by increasing the rate of these outcomes 
in women with a normal glucose tolerance test. The inter-
relationship between hypertension and macrosomia rates to 
BMI has been previously demonstrated in the same population.9 
The present study further suggests that fasting blood glucose 
values appear to be better indicators of risk and that cut-off risk-
significant values may need to be further reduced to 4.6 mmol/l 
rather than the currently established value of 5.3 mmol/l.
Women with defined mild gestational carbohydrate 
intolerance with 2-hour post-load values of 8.6-9.5 mmol/l 
showed no statistically increased risk for short-term morbidity. 
These women have however been shown to have long-term 
morbidities related to subsequent onset of carbohydrate 
intolerance. Maltese women with a borderline or mild 
carbohydrate intolerance during pregnancy have been shown 
to be 3.6 times more likely to develop an abnormal glucose 
tolerance eight years postpartum when compared to women 
with a normal glucose tolerance test as defined by the WHO 
criteria.10 In spite of the apparent absence of short-term effects 
of mild GIGT, it may remain prudent to continue advising 
women with a borderline glucose tolerance test to reduce their 
refined sugar intake, thus reducing the day-to-day blood glucose 
loads presented to the developing fetus. The long-term risks to 
the woman need also be discussed during the antenatal and 
postpartum visits in order that lifestyle modifications may be 
made to reduce or delay the advent of adult-onset diabetes.
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